The WellDoc System addresses a pressing need for innovative approaches to diabetes treatment. In development for more than five years, the DiabetesManager System supports medication adherence and securely provides for the capture, storage, and real-time transmission of blood glucose data and other diabetes self-management information. This information is then analyzed by the company's proprietary Automated Expert Analytics System?„?, which identifies trends and then delivers relevant educational and behavioral patient coaching and provider decision support, thus enabling effective lifestyle and medication adjustments.

"With the WellDoc DiabetesManager System, we provide the medical community with decision-support tools that can help doctors and patients work together to manage diabetes more effectively," said Suzanne Sysko Clough, M.D., founder and chief medical officer of WellDoc. "WellDoc products are rigorously developed by our clinical staff using evidence-based guidelines and then tested for their impact on health outcomes. Patients and providers expect a certain quality level from all medical devices, including mHealth solutions, so obtaining FDA clearance is a critical milestone."

The company intends to commercially launch the WellDoc DiabetesManager System in early 2011, and will be an exhibitor in the inaugural Mobile Health Pavilion at the annual meeting of the American Association of Diabetes Educators (AADE), August 4-7 in San Antonio.

SOURCE WellDoc